<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27828641</article-id>
      <article-id pub-id-type="pmc">5087226</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20164778</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ofuji disease: a rare dermatosis and its challenging therapeutic
approach<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>de Brito</surname>
            <given-names>Fernanda Freitas</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martelli</surname>
            <given-names>Antonio Carlos Ceribelli</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cavalcante</surname>
            <given-names>Maria Lopes Lamenha Lins</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Ana Cec&#xED;lia Versiani Duarte</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Itimura</surname>
            <given-names>Gabriela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Soares</surname>
            <given-names>Cleverson Teixeira</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Instituto Lauro de Souza Lima (ILSL) &#x2013; Bauru (SP),
Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Mailing address: Fernanda Freitas de Brito, Rodovia Comandante
Jo&#xE3;o Ribeiro de Barros, km 225/226 Distrito Industrial, 17039-800 - Bauru
- SP Brazil. E-mail:
<email>fernandabrito.dermatologia@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>5</issue>
      <fpage>646</fpage>
      <lpage>648</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <copyright-holder>Anais Brasileiros de Dermatologia</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Eosinophilic pustular folliculitis (EPF) or Ofuji disease is a rare dermatosis,
prone to recurrence and chronicity. The peak incidence occurs in the third
decade of life and its exact etiology remains unknown. Evidence suggests that
the expression of adhesion molecules and the production of cytokines activate
the follicular unit, but the stimulus that triggers these changes remains
unclear. The three clinical variants reported in the literature include classic
EPF, immunosuppression-associated EPF, and infancy-associated EPF. We report a
case of eosinophilic pustular folliculitis with peculiar epidemiological
characteristics, which represents a challenging therapeutic scenario.</p>
      </abstract>
      <kwd-group>
        <kwd>Skin Diseases</kwd>
        <kwd>Pregnancy</kwd>
        <kwd>HIV</kwd>
        <kwd>Neutrophil infiltration</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Eosinophilic pustular folliculitis (EPF) or Ofuji disease is a rare dermatosis, prone
to recurrence and chronicity. The peak incidence occurs in the third decade of
life.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> In 1965, Ise and Ofuji described a case of a
Japanese woman supposedly presenting a follicular variant of subcorneal pustular
dermatosis.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Her clinical
picture consisted of follicular pustules on the face, back, and arms, as well as
moderate leukocytosis with eosinophilia.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> In 1970, Ofuji <italic>et al.</italic> published three other
cases proposing the term "eosinophilic pustular folliculitis".<sup><xref rid="r4" ref-type="bibr">4</xref></sup> The first cases in children were
described by Lucky in 1984.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> Two
years later, Soeprono and Schinella reported three cases of EPF in patients with
HIV.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> The exact etiology of
the disease remains unknown. Evidences suggest that the expression of adhesion
molecules and the production of cytokines activate the follicular unit, but the
stimulus that triggers these changes remains unclear. Factors that seem to induce
EPF include hypersensitivity reactions, mites, fungal infections, abnormal
eosinophils or T lymphocyte function, immune dysfunction caused by human
immunodeficiency virus (HIV), and reconstitution of immune function in patients
treated for HIV.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> The literature reports three clinical variants of
the disease. Classic EPF is more frequent in Japan with a male predominance.
Clinically, it is characterized by papular pustules (1-2mm in diameter) with a
tendency to increase in size and merge, leading to the formation of erythematous
plaques. Lesions are usually follicular and pruritic, chronic, and recurrent, with
centrifugal extension and central clearing. Lesions typically take 7-10 days to heal
and recur every 3-4 weeks. Classic EPF mainly affects the face and trunk. Less
frequently, it can compromise extremities, palms and soles.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> Immunosuppression-associated EPF is the most common variant,
often related to HIV infection. It mostly affects late-stage patients and/or with
CD4 lymphocyte count below 250-300 cells/mm<sup>3</sup>.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> Infancy-associated EPF first appears
between the second and tenth months of life, with papular-pustular lesions similar
to the classic variant. However, lesions are almost exclusively seen on the scalp
and without the characteristic annular pattern.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> We report a case of
eosinophilic pustular folliculitis with peculiar epidemiological characteristics and
its challenging therapeutic approach.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 29-year-old female patient referred to our institution with pruritic papular
pustules on the face and upper limbs. She reported having used hair dye 15 days
before the appearance of the lesions. Personal history revealed no comorbidities.
Dermatological exam showed follicular papules and pustules, coalescing to form
plaques on the face and extensor region of the upper limbs (<xref ref-type="fig" rid="f1">Figures 1</xref> and <xref ref-type="fig" rid="f2">2</xref>). Anatomic
pathological examination revealed dermal inflammation, mostly composed of
eosinophils and, to a lesser extent, neutrophils and mononuclear cells with
follicular aggression &#x2013; clinical picture suggestive of EPF (<xref ref-type="fig" rid="f3">Figure 3</xref>). Patch test had positive reaction to lanolin,
paraben-mix, and formaldehyde. Blood count revealed mild leukocytosis (11,500
cells/mm<sup>3</sup> &#x2013; reference range (RR): 4500-11000 cells/mm<sup>3</sup>)
with eosinophilia (6% - RR: 0%-5%). Serological tests for hepatitis B and C and HIV
revealed negative results. Treatment started with cetirizine, topical corticosteroid
and indomethacin. The patient improved considerably, but presented relapses when we
reduced indomethacin dosage. After one year of treatment, the patient tested
positive on beta-HCG (human chorionic gonadotropin). We suspended all medications
and the patient showed total improvement of the lesions during pregnancy. In the
first week after giving birth, the lesions on the face recurred, but resolved
spontaneously after three days. The patient has been follow-up since then and we
have reported no recurrent lesions for three years.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>A.</bold> Follicular papules and pustules, coalescing to form
plaques in frontal and right perioral areas. <bold>B.</bold> Details of
confluent follicular papules forming erythematous plaques on the
forehead. <bold>C.</bold> Detail of follicular papules on perioral
area</p>
          </caption>
          <graphic xlink:href="abd-91-05-0646-g01"/>
        </fig>
      </p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>A and B</bold>. Follicular papules and pustules, some excoriated,
on the extensor region of the upper limbs</p>
          </caption>
          <graphic xlink:href="abd-91-05-0646-g02"/>
        </fig>
      </p>
      <p>
        <fig id="f3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>A.</bold> HE 50x: Folliculotropic inflammatory process in the
superficial and deep dermis; <bold>B.</bold> HE 100x: Predominantly
neutrophilic and eosinophilic inflammatory process with follicular
aggression and basophilic material deposited in the follicular
epithelium and interstitial; <bold>C.</bold> HE 400x: Intense follicular
aggression mediated by eosinophils and neutrophils</p>
          </caption>
          <graphic xlink:href="abd-91-05-0646-g03"/>
        </fig>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>EPF is a pruritic cutaneous eruption that mainly occurs in Japanese people.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup> Although HIV-associated EPF is the prevalent variant, our
patient presented negative HIV serological examination. Our case was consistent with
the classical variant of the disease (originally described by Ofuji), but the
lesions affected a female western patient, which makes our case a rare occurrence.
Laboratory tests showed mild leukocytosis with eosinophilia. Ofuji described the
presence of peripheral eosinophilia in all of his cases. This change, however, is
not always present.<sup><xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup> Another laboratory finding of the
classic variant includes mild-to-moderate leukocytosis.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup> The etiology
of the disease remains unknown, but in the present report &#x2013; due to the chronological
association of the skin lesions with hair dye use &#x2013; we suggest that a
hypersensitivity reaction may have triggered the lesions. Our diagnosis was made on
clinical grounds based on anatomic pathological examination. The results showed
inflammatory dermal infiltration mostly composed of eosinophils and neutrophils (to
a lesser extent) and mononuclear cells with follicular aggression.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup> Although various
treatments have been attempted for EPF, the use of topical corticosteroids is
usually the treatment of choice for all variants with satisfactory
response.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> Indomethacin tends to be the oral treatment of
choice for the classic variant, but relapse cases are frequently reported.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r9" ref-type="bibr">9</xref></sup> Other treatment
options include topical calcineurin inhibitors, systemic isotretinoin, phototherapy,
minocycline, doxycycline, sulfamethoxazole/trimethoprim, erythromycin, dapsone,
colchicine, and clofazimina.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> Our patient used topical steroids associated with antihistamine
and indomethacin showing lesion stability. However, we reported recurrence after a
decrease in indomethacin dose. According to the literature, immune diseases can
improve or worsen during pregnancy.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> In the present case, we reported an overall clinical
improvement during pregnancy. After delivery, lesions recurred and resolved
spontaneously in three days. Due to recurrence and chronicity, EPF is difficult to
treat. This report highlights the importance of considering EPF not only for Asian
immunosuppressed patients and emphasizes the rarity of this disease that poses a
therapeutic challenge to clinicians.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at Instituto Lauro de Souza Lima (ILSL) &#x2013; Bauru (SP), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Razera</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Olm</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Bonamigo</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Dermatoses neutrof&#xED;licas - Parte II</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>195</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="pmid">21603801</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ellis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Scheinfeld</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Eosinophilic pustular folliculitis A comprehensive review of
treatment options</article-title>
          <source>Am J Clin Dermatol</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>189</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="pmid">15186198</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ise</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ofuji</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Subcorneal pustular dermatosis A follicular
variant?</article-title>
          <source>Arch Dermatol</source>
          <year>1965</year>
          <volume>92</volume>
          <fpage>169</fpage>
          <lpage>171</lpage>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nervi</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Dmochowski</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Eosinophilic pustular folliculitis: A 40 year
retrospect</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2006</year>
          <volume>55</volume>
          <fpage>285</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">16844513</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larralde</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morales</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Santos Mu&#xF1;oz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lamas</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schroh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Corbella</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Eosinophilic pustular in infancy: report of two new
cases</article-title>
          <source>Pediatr Dermatol</source>
          <year>1999</year>
          <volume>16</volume>
          <fpage>118</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="pmid">10337675</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sufyan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>Eosinophilic pustular folliculitis</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2007</year>
          <volume>131</volume>
          <fpage>1598</fpage>
          <lpage>1601</lpage>
          <pub-id pub-id-type="pmid">17922601</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenthal</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>LeBoit</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Klumpp</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus-associated eosinophilic folliculitis
A unique dermatosis associated with advanced human immunodeficiency virus
infection</article-title>
          <source>Arch Dermatol</source>
          <year>1991</year>
          <volume>127</volume>
          <fpage>206</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="pmid">1671328</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishiguro</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shishido</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Igarashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Ofuji's disease: a report of 20 patients with clinical and
histopathologic analysis</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2002</year>
          <volume>46</volume>
          <fpage>827</fpage>
          <lpage>833</lpage>
          <pub-id pub-id-type="pmid">12063478</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fukamachi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kabashima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sugita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tokura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic effectiveness of various treatments for eosinophilic
pustular folliculitis</article-title>
          <source>Acta Derm Venereol</source>
          <year>2009</year>
          <volume>89</volume>
          <fpage>155</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">19326000</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guti&#xE9;rrez</surname>
              <given-names>HIG</given-names>
            </name>
            <name>
              <surname>I&#xF1;iguez</surname>
              <given-names>MJC</given-names>
            </name>
            <name>
              <surname>Mendoza</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Enfermedad de Ofuji y embarazo Comunicaci&#xF3;n de un
caso</article-title>
          <source>Ginecol Obstet Mex</source>
          <year>2006</year>
          <volume>74</volume>
          <fpage>158</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">16886758</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
